From survival to survivorship:
Shifting the focus to living well with cancer and beyond
Sponsored by
*This project was commissioned, funded and reviewed by Pfizer Inc. Economist Enterprise performed the research independently and retained full editorial control.
Our research aims to transform how we measure success in cancer care—shifting the focus from solely survival to survivorship. By integrating real-world insights and diverse stakeholder perspectives, the framework highlights key indicators for progress across the entire cancer journey. From access to care to economic and financial considerations, we take a holistic view of cancer to ensure that every patient receives the support they need to survive and live well with and beyond cancer.
The findings and views expressed do not necessarily reflect the views of the sponsor. Economist Enterprise retains full editorial control over research and is solely responsible for all content.
